ADVISORSHARES PSYCHEDELICS ETF Newsroom

What's Going On With NRX Pharmaceuticals Stock Thursday?

Benzinga02:14

NRX Pharmaceuticals Shares Are Trading Higher After the Company Announced a Joint-acquisition Initiative With NRx Pharmaceuticals to Buy the Kadima Neuropsychiatry Institute.

BenzingaJan 2 23:06

Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket

BenzingaJan 2 19:40

Why Is Penny Stock Clearmind Gaining Today?

BenzingaDec 25, 2024 00:32

Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?

BenzingaDec 22, 2024 22:51

ADVISORSHARES PSYCHEDELICS ETF To Go Ex-Dividend On December 23rd, 2024 With 0.05477 USD Dividend Per Share

December 20th (Eastern Time) - $ADVISORSHARES PSYCHEDELICS ETF(PSIL.US)$ is trading ex-dividend on December 23rd, 2024.Shareholders of record on December 23rd, 2024 will receive 0.05477 USD dividend

Futu NewsDec 21, 2024 09:05

Needham Reiterates Hold on Neurocrine Biosciencesto Hold

BenzingaDec 20, 2024 23:52

MindMed To Be Added To The Nasdaq Biotechnology Index, Effective At Market Open On December 23, 2024

BenzingaDec 19, 2024 20:10

Mind Medicine Analyst Ratings

BenzingaDec 18, 2024 00:09 · Ratings

Summit Therapeutics Shares Are Trading Higher. The Stock May Be Moving in Sympathy With Neurocrine Biosciences Which Received FDA Approval for CRESNESSITY.

BenzingaDec 17, 2024 04:23

Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential

BenzingaDec 16, 2024 22:10

Wedbush Reiterates Outperform on Neurocrine Biosciences, Maintains $148 Price Target

BenzingaDec 16, 2024 21:25 · Ratings

Reported Friday, Neurocrine Biosciences' CRENESSITY Receives FDA Approval, Revolutionizing Treatment For Classic Congenital Adrenal Hyperplasia

BenzingaDec 16, 2024 15:30

"Laggard" Stocks With Expanding FCF Margins and Attractive FCF Yields – Goldman

Seeking AlphaDec 6, 2024 02:43

MindMed Awarded Innovation Passport Designation By United Kingdom Innovative Licensing And Access Pathway Steering Group For MM120 Orally Disintegrating Tablet For Generalized Anxiety Disorder

BenzingaDec 5, 2024 20:07

Screening For Black Friday Bargains In The Stock Market

BenzingaDec 3, 2024 22:21

Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%

Seeking AlphaNov 28, 2024 01:16

HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $19 Price Target

BenzingaNov 25, 2024 21:38 · Ratings

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaNov 20, 2024 05:05

ATAI Life Sciences Analyst Ratings

BenzingaNov 18, 2024 22:16 · Ratings